195 related articles for article (PubMed ID: 2436752)
1. Altered expression of beta-globin, transferrin receptor, and ornithine decarboxylase in Friend murine erythroleukemia cells inhibited by alpha-difluoromethylornithine.
Klinken SP; Billelo J; Bauer S; Morse HC; Thorgeirsson SS
Cancer Res; 1987 May; 47(10):2638-44. PubMed ID: 2436752
[TBL] [Abstract][Full Text] [Related]
2. D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells.
Choudhary SK; Sharma D; Dixit A
Cell Biol Int; 1999; 23(7):489-95. PubMed ID: 10728786
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
5. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
Watanabe T; Shafman T; Kufe DW
J Cell Physiol; 1985 Mar; 122(3):435-40. PubMed ID: 3918047
[TBL] [Abstract][Full Text] [Related]
6. [Expression of transferrin receptor and ferrochelatase mRNAs in MEL cells].
Wang W; Li R; Chen J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):17-20. PubMed ID: 11498837
[TBL] [Abstract][Full Text] [Related]
7. Effects of retinoic acid versus dimethyl sulfoxide on Friend erythroleukemia cell growth. I. Cell proliferation, RNA content, and protein content.
Traganos F; Bueti C; Darzynkiewicz Z; Melamed MR
J Natl Cancer Inst; 1984 Jul; 73(1):193-204. PubMed ID: 6588224
[TBL] [Abstract][Full Text] [Related]
8. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS; Wong W
Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
[TBL] [Abstract][Full Text] [Related]
10. Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.
Gazitt Y; Friend C
Cancer Res; 1980 May; 40(5):1727-32. PubMed ID: 6154532
[TBL] [Abstract][Full Text] [Related]
11. Effects of polyamine depletion on proliferation and differentiation of murine erythroleukemia cells.
Sugiura M; Shafman T; Kufe D
Cancer Res; 1984 Apr; 44(4):1440-4. PubMed ID: 6423275
[TBL] [Abstract][Full Text] [Related]
12. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
Lo SC; Aft R; Mueller GC
Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
[TBL] [Abstract][Full Text] [Related]
13. Control of globin synthesis during DMSO-induced differentiation of mouse erythroleukemic cells in culture.
Gaedicke G; Abedin Z; Dube SK; Kluge N; Neth R; Steinheider G; Weimann BJ; Ostertag W
Hamatol Bluttransfus; 1974; 14():278-87. PubMed ID: 4532097
[No Abstract] [Full Text] [Related]
14. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
15. Early changes in ornithine decarboxylase activity and polyamines during erythroid differentiation of Friend leukemia cells.
Morioka K; Tanaka K; Kezuka Y; Suganuma K; Yui K; Ono T
Oncodev Biol Med; 1983; 4(3):231-7. PubMed ID: 6572360
[TBL] [Abstract][Full Text] [Related]
16. Iron-responsive element-binding protein mRNA levels during erythroid differentiation of murine erythroleukemia cells.
Fuchs O
Neoplasma; 1995; 42(4):179-85. PubMed ID: 7659183
[TBL] [Abstract][Full Text] [Related]
17. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
[TBL] [Abstract][Full Text] [Related]
18. Distribution of globin genes and histone variants in micrococcal nuclease-generated subfractions of chromatin from Friend erythroleukemia cells at different malignant states.
Leonardson KE; Levy SB
J Cell Biochem; 1994 Jan; 54(1):110-21. PubMed ID: 8126082
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
Sherman ML; Shafman TD; Kufe DW
J Cell Physiol; 1988 Mar; 134(3):429-36. PubMed ID: 2450878
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the differentiation of 3T3-L1 cells by interferon-beta and difluoromethyl ornithine.
Taylor JL; Turo KA; McCann PP; Grossberg SE
J Biol Regul Homeost Agents; 1988; 2(2):99-104. PubMed ID: 3142219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
